Back to Search Start Over

Prognostic Implications of the Timing of ST-Elevation Myocardial Infarction Development in Relation to COVID-19 Infection.

Authors :
Milošević, Aleksandra D.
Polovina, Marija M.
Jelic, Dario D.
Simic, Damjan D.
Viduljevic, Mihajlo M.
Matic, Dragan M.
Tomic, Milenko M.
Adzic, Tatjana N.
Asanin, Milika R.
Source :
Journal of Intensive Care Medicine. Aug2024, Vol. 39 Issue 8, p801-805. 5p.
Publication Year :
2024

Abstract

Background: Patients with ST-segment elevation myocardial infarction (STEMI) and COVID-19 infection have a worse clinical course and prognosis. The prognostic significance of the timing of STEMI in relation to COVID-19 infection was not investigated. Objectives: To assess whether the time of STEMI development in relation to COVID-19 infection (concurrent or following the infection) influenced the short-term prognosis. Methods: This was an observational study of consecutive COVID-19 patients with STEMI admitted to the COVID-hospital Batajnica (February 2021–March 2022). The patients were divided into the "STEMI first" group: patients with STEMI and a positive polymerase chain reaction test for COVID-19, and the "COVID-19 first" group: patients who developed STEMI during COVID-19 treatment. All patients underwent coronary angiography. The primary endpoint was in-hospital all-cause mortality. Results: The study included 87 patients with STEMI and COVID-19 (M age, 66.7 years, 66% male). The "STEMI first" group comprised 54 (62.1%) patients, and the "COVID-19 first" group included 33 (37.9%) patients. Both groups shared a comparatively high burden of comorbidities, similar angiographic and procedural characteristics, and high percentages of performed percutaneous coronary interventions with stent implantation (90.7% vs. 87.9%). In-hospital mortality was significantly higher in the "COVID-19 first" group compared to the "STEMI first" group (51.5% vs. 27.8%). Following adjustment, the "COVID-19 first" group had a hazard ratio of 3.22 (95% confidence interval, 1.18–8.75, p =.022) for in-hospital all-cause death, compared with the "STEMI first" group (reference). Conclusion: Clinical presentation with COVID-19 infection, followed by STEMI ("COVID-19 first"), was associated with greater short-term mortality compared to patients presenting with STEMI and testing positive for COVID-19 ("STEMI first"). [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
08850666
Volume :
39
Issue :
8
Database :
Academic Search Index
Journal :
Journal of Intensive Care Medicine
Publication Type :
Academic Journal
Accession number :
178804610
Full Text :
https://doi.org/10.1177/08850666241232938